SEER, US8158581079

Seer stock reacts to CFO resignation and leadership reshuffle

Published on 09/20/2026 at 19:29 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS

Seer stock trades near USD 2.05 on Nasdaq as of September 20, 2026 after the company announced CFO David Horn’s resignation effective October 1, 2026. The latest quarterly figures show revenue of USD 4.0 million with a net loss of USD 21.74 million in Q1/2025.

SEER, US8158581079, Illustration mit AI erstellt.
SEER, US8158581079, Illustration mit AI erstellt.

Seer stock (ISIN US8158581079) is trading around USD 2.05 on Nasdaq as of September 20, 2026, leaving investors to weigh a recent leadership change against still loss-making fundamentals in the most recently reported quarter.

CFO resignation reshapes Seer’s leadership

According to The Globe and Mail on September 19, 2026, Seer, Inc. announced that president, chief financial officer and treasurer David Horn resigned effective October 1, 2026, with the company stating that his departure was not due to any operational disagreement.

In the same update, Seer said that chief executive officer and chair Omid Farokhzad will also assume the role of president, while Charles Endweiss, previously vice president of financial planning and analysis, has been promoted to treasurer, principal financial officer and principal accounting officer, consolidating the company’s top leadership roles while elevating internal finance talent.The Globe and Mail

Recent fundamentals highlight ongoing losses

Trading data from a Nasdaq-focused portal show that Seer stock is quoted at about USD 2.05, up 0.49% over the last 24 hours as of September 20, 2026, with the shares gaining 24.24% over the past month but still down 4.65% over the last year, illustrating a short-term recovery on a longer-term weak performance base.TradingView

According to the same TradingView data, Seer generated revenue of USD 4.0 million in its last reported quarter, modestly above an analyst estimate of USD 3.95 million, while posting a net loss of USD 21.74 million compared with a net loss of USD 21.33 million in the prior quarter, a deterioration of 1.94% that underscores persistent cash burn despite slightly better top-line momentum in Q1/2025.TradingView

The same overview indicates that Seer reported earnings per share of minus USD 0.37 in the last quarter against a consensus forecast of minus USD 0.39, a positive surprise of 4.31%, and that the trailing twelve-month earnings per share stand at about minus USD 1.39, highlighting that while quarterly results came in slightly better than expected, the company remains deeply loss-making on a full-year basis.TradingView

Analyst view and risk profile

TipRanks’ AI-based Spark analyst characterizes Seer as Neutral, constrained primarily by very large losses and persistent cash burn despite improved gross margin and low leverage, with technical signals described as mixed and valuation difficult to support in the absence of positive earnings and a dividend.The Globe and Mail

That same Spark assessment notes that Seer’s latest earnings call offered modest support via reaffirmed guidance, strong cash resources and share buybacks, but also pointed to near-term commercial headwinds and a year-over-year revenue decline as key risks, suggesting that any potential re-rating of Seer stock will hinge on concrete progress in translating its proteomics platform into sustainable, growing revenue.

Stock price and trading context

Per the TradingView snapshot, Seer stock’s recent price of around USD 2.05 on Nasdaq as of September 20, 2026 sits between the 52-week high and 52-week low reported by the portal, and the shares have risen 3.02% over the past week and 24.24% over the past month, indicating that despite ongoing losses and management changes, market participants have recently been willing to pay a slightly higher price for the stock than in prior weeks.TradingView

Seer stock key data

  • Company: Seer, Inc.
  • ISIN: US8158581079
  • Ticker: SEER
  • Trading venue: Nasdaq
  • Price (as of September 20, 2026): 2.05 USD
  • Market capitalization: Data per Nasdaq-focused portals (as of September 20, 2026)
  • Sector / Industry: Health Care / Life Sciences Tools
  • Index membership: None major index (e.g., S&P 500)

More news and analyses on Seer stock

Disclaimer...

en | US8158581079 | SEER | boerse | 70139216 | bgmi